Triple-negative breast cancer (TNBC) is a subtype of breast cancer,1,2 characterized by the lack of expression of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor-2 protein (HER2).3 This evidence concerns the gene ESR1 and breast carcinoma.